Key facts: AstraZeneca's stock closed at 12,436.00 pence, up 1,254.00 pence (11.21%), and at 1,568.00 SEK, up 148.00 SEK (10.42%) in the latest trading session.
Займёт меньше минуты
- AstraZeneca's stock closed at 12,436.00 pence, up 1,254.00 pence (11.21%), and at 1,568.00 SEK, up 148.00 SEK (10.42%) in the latest trading session.1
- AstraZeneca will invest $50 billion in U.S. manufacturing by 2030, including a major facility in Virginia and expansions in several states, while managing inventory for upcoming tariffs.2
- AstraZeneca announced a new initiative to sell its diabetes and asthma drugs directly to cash-paying patients in the U.S., offering discounts of up to 70% off list prices.3